Our Vision
Ride Tide
The greatest danger in times of turbulence, is not the turbulence, it’s acting with yesterday’s logic.
– Peter Drucker –
OPERATIONAL AGILITY
NETWORKING
DIGITAL TRANSFORMATION
About the factories
An extensive range of production facilities and production capabilities for variable demand and production tailored to each process
Jeju Plant
BMI KOREA’s Jeju Plant is a production base for manufacturing injections and pharmaceutical ingredients.
Osong Plant
Built in 2022, this plant is designed to manufacture recombinant pharmaceutical proteins through animal cell culture.
Products
CDMO
BMI KOREA is engaged in the outsourced development and production of high-quality biopharmaceutical drugs based on its best-in-class production facilities and outstanding technological prowess, and it continues to expand its business portfolio to keep pace with the evolving demands of the global pharmaceutical industry.
Development/optimization of production process
Pre-clinical production
GMP manufacturing
